\
&
Contact us
Published on | 1 year ago
ProgrammesThe opening of the Postdoctoral Fellowships call 2025 will be postponed by one month, from 9 April to 8 May 2025. The closing date remains the same. As with previous calls the MSCA PF 2025 call will be eventually included on the European Commission Funding and Tenders portal.
To minimise the impact of the shortened application period, all information documents such as the Guide for Applicants, (static) application form, etc. will be uploaded in advance so that applicants are fully aware of all the call conditions.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment Horizontal Activities
After lengthy discussions, the final work programme on the horizontal activities has been officially published on the website of the European Commission. First added to Horizon Europe in 2025, this broadly defined work programme supports EU policy goals through four topics: the Clean Industrial Deal, AI in Science, a nature-positive economy... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.